Keytruda Archives - World School of Life Sciences IP

U.S. FDA approval of BioLineRx’s APHEXDA™ (Motixafortide) in combination with Filgrastim (G-CSF) – a ray of hope for patients with Multiple Myeloma

Tanu Goyal September 20, 2023

U.S. FDA approval of BioLineRx’s APHEXDA™ (Motixafortide) in combination with Filgrastim (G-CSF) – a ray of hope for patients with Multiple Myeloma BioLineRx Ltd., a

WSLI

Welcome to World School of Life Sciences IP, a pioneer in empowering minds to dominate the ever-evolving landscape of patents and pharmaceutical innovations.